Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 1
2007 1
2008 3
2009 7
2010 2
2011 4
2012 4
2013 4
2014 4
2015 6
2016 3
2017 6
2018 5
2019 6
2020 7
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
Leong DP, Fradet V, Shayegan B, Duceppe E, Siemens R, Niazi T, Klotz L, Brown I, Chin J, Lavallee L, Mousavi N, Luke P, Lukka H, Gopaul D, Violette P, Hamilton RJ, Davis MK, Karampatos S, Mian R, Delouya G, Fradet Y, Mukherjee S, Conen D, Chen-Tournoux A, Johnson C, Bessissow A, Dresser G, Hameed AK, Abdel-Qadir H, Sener A, Pal R, Devereaux PJ, Pinthus J. Leong DP, et al. Among authors: fradet v. J Urol. 2020 Jun;203(6):1109-1116. doi: 10.1097/JU.0000000000000714. Epub 2020 Jan 3. J Urol. 2020. PMID: 31899651
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.
Guertin MH, Robitaille K, Pelletier JF, Duchesne T, Julien P, Savard J, Bairati I, Fradet V. Guertin MH, et al. Among authors: fradet v. BMC Cancer. 2018 Jan 10;18(1):64. doi: 10.1186/s12885-017-3979-9. BMC Cancer. 2018. PMID: 29321047 Free PMC article. Clinical Trial.
Building a Canadian Translational Bladder Cancer Research Network.
Koti M, Berman DM, Siemens DR, Lange D, Wang E, Toren P, Eigl BJ, Hardy C, Purves R, Fradet V, Fradet Y, Mansure J, Kassouf W, Black PC; Canadian Bladder Cancer Research Network. Koti M, et al. Among authors: fradet v. Can Urol Assoc J. 2020 Oct;14(10):E475-E481. doi: 10.5489/cuaj.6887. Can Urol Assoc J. 2020. PMID: 33275556 Free PMC article. No abstract available.
Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity.
Gevariya N, Lachance G, Robitaille K, Joly Beauparlant C, Beaudoin L, Fournier É, Fradet Y, Droit A, Julien P, Marette A, Bergeron A, Fradet V. Gevariya N, et al. Among authors: fradet v. Mol Cancer Res. 2020 Dec 1. doi: 10.1158/1541-7786.MCR-20-0316. Online ahead of print. Mol Cancer Res. 2020. PMID: 33262291
Psychological morbidity associated with prostate cancer: Rates and predictors of depression in the RADICAL PC study.
Fervaha G, Izard JP, Tripp DA, Aghel N, Shayegan B, Klotz L, Niazi T, Fradet V, Taussky D, Lavallée LT, Hamilton RJ, Brown I, Chin J, Gopaul D, Violette PD, Davis MK, Karampatos S, Pinthus JH, Leong DP, Biostat M, Siemens DR; RADICAL PC Investigators. Fervaha G, et al. Among authors: fradet v. Can Urol Assoc J. 2020 Nov 17. doi: 10.5489/cuaj.6912. Online ahead of print. Can Urol Assoc J. 2020. PMID: 33212008
Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.
Bilodeau JF, Gevariya N, Larose J, Robitaille K, Roy J, Oger C, Galano JM, Bergeron A, Durand T, Fradet Y, Julien P, Fradet V. Bilodeau JF, et al. Among authors: fradet v. Prostaglandins Leukot Essent Fatty Acids. 2021 Jan;164:102215. doi: 10.1016/j.plefa.2020.102215. Epub 2020 Nov 19. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 33276284
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page